GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Operating Margin %

Yunkang Group (HKSE:02325) Operating Margin % : -6.73% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Yunkang Group's Operating Income for the six months ended in Dec. 2023 was HK$-30.5 Mil. Yunkang Group's Revenue for the six months ended in Dec. 2023 was HK$453.5 Mil. Therefore, Yunkang Group's Operating Margin % for the quarter that ended in Dec. 2023 was -6.73%.

The historical rank and industry rank for Yunkang Group's Operating Margin % or its related term are showing as below:

HKSE:02325' s Operating Margin % Range Over the Past 10 Years
Min: -7.76   Med: 8.37   Max: 28.3
Current: -0.85


HKSE:02325's Operating Margin % is ranked better than
56.42% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.795 vs HKSE:02325: -0.85

Yunkang Group's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Yunkang Group's Operating Income for the six months ended in Dec. 2023 was HK$-30.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-8.3 Mil.

Warning Sign:

Yunkang Group Ltd has recorded a loss in operating income at least once over the past 3 years.


Yunkang Group Operating Margin % Historical Data

The historical data trend for Yunkang Group's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group Operating Margin % Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial -0.01 27.93 28.30 16.75 -0.85

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only 30.31 22.37 13.49 4.26 -6.73

Competitive Comparison of Yunkang Group's Operating Margin %

For the Diagnostics & Research subindustry, Yunkang Group's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Yunkang Group's Operating Margin % falls into.



Yunkang Group Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Yunkang Group's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-8.289 / 975.104
=-0.85 %

Yunkang Group's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-30.526 / 453.519
=-6.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yunkang Group  (HKSE:02325) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Yunkang Group Operating Margin % Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group (HKSE:02325) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines